Aging Overview

External factors

External factors: Supraphysiological and rogen
Aging type: Accelerate
Aging characteristic:
Category: Other
Phenotype: Prostate cancer
Experimental category: L
Tissue type: Prostate
Cell name: LNCaP,C4-2
PMID: 25216853
Experiment: SA-β-gal activity assay//SAHF//DAPI staining
Description: We observed that both the natural and the synthetic androgen induce cellular senescence in a concentration-dependent manner. Administration of 1 nM R1881 or 1 nM DHT indicate a strong induction of SA β-Gal activity, in contrast,lower androgen levels show the basal level of cellular senescence similar to the untreated or the solvent control.To confirm the androgen-induced cellular senescence,we examined a further marker, the formation of senescence-associated heterochromatic foci (SAHF).DAPI staining of the treated cells revealed that SAL treatment induces an accumulation of heterochromatin in LNCaP cells.


Regulatory relationship

Regulatory pathway: p16-pRb-E2F1//Src-Akt-Mtor
R-EF-Pathway: --//--
Official symbol(s): CDKN2A-RB1-E2F1//SRC-AKT-MTOR
Pathway experiment: Western blot//qRT-PCR//SA-β-gal activity assay
Pathway description: p16-pRb-E2F1:After administration of SAL an upregulation of p16, hypophosphorylation of pRb and down-regulation of the pRb targets Cyclin D1 as well as of E2F1 protein levels were observed indicating that the p16-pRb pathway is regulated by SAL treatment .Similar results were obtained by treating the cells for 6 days. In contrast, LAL treatment mediated no detectable changes of p16,Cyclin D1 and E2F1 expression level. In line with this,SAL treatment led to inhibition of down-stream targets of pRB, Cyclin D1 as well as E2F1 at mRNA level, whereas the p16 mRNA is upregulated by SAL doses. Accordingly, the mRNA level of ID1, an inhibitor of p16 expression, is reduced upon SAL administration . Thus, these data indicate that the p16-pRb-E2F1 pathway is associated with the androgen-mediated cellular senescence.Src-Akt-mTOR :Notably, treatment of LNCaP cells with the Src inhibitor PP2 under SAL conditions reduces the androgen-mediated cellular senescence. In contrast, inhibition of Src without androgens or with LAL has no detectable influence on the SA β-Gal activity in LNCaP cells compared to control. Akt phosphorylation is a well-known pathway of the Src tyrosine kinase and involves signaling molecules such as the PI3K as well as the mammalian target of rapamycin (mTOR). Using inhibitors the role of these factors in androgen-mediated cellular senescence was analyzed. Inhibition of PI3K, an Akt-activating kinase,by the 3-MA inhibitor, reduced the level of androgen-induced cellular senescent cells, which confirms that the Src-Akt signaling pathway is involved in androgen-induced cellular senescence at supraphysiological levels. Similarly, using a specific Akt-kinase inhibitor(Akti) reveals a strong reduction of the SAL-mediated SAβ-Gal activity. A further downstream target of the Src- and the Akt-kinase is mTOR, which is involved in proliferation and cell cycle regulation processes [35]. Rapamycin alone mediates no detectable change in the level of cellular senescence. In contrast, rapamycin co-treated with SAL resulted in reduction of SA β-Gal positive stained cells.The data show that rapamycin reduces the androgen-mediated SA β-Gal activity and suggest that mTOR is partially involved in androgen-mediated cellular senescence. This supports the notion that the Src-Akt-mTOR signaling mediates the androgen-mediated induction of cellular senescence.


Aging network

Annotation:

The green line represents Upregulation.

The purple line represents Downregulation.

The orange line represents Activation.

The yellow line represents Inhibition.

The gray line represents Unclear.



Pathway view